garrett evans

FILTRONIC well worth a read

@DomPosen Great bit of research ahead. Of the game with today's RNS

10/10 Bottom line: This publication raises the ceiling for how foralumab is valued and lowers the bar for strategic interest. It’s quiet, technical, and very important. $TLSA #Biotech #Neurodegeneration

1/10 Important but overlooked development for $TLSA: A peer-reviewed paper on intranasal foralumab & microglial PET in non-active SPMS has now been formally published. neurology.org/doi/10.1212/NX… This is not PR — it’s mechanistic validation. #multiplesclerosis

@Wisdom_HQ 116

@DomPosen Great thread we'll done for taking the time to create it.

17/17 These are only my personal opinions based on publicly available information. This is not financial advice. Everyone should do their own research and make their own decisions when investing.

1/17 I decided to write this thread because there are roughly 27 trading days left before the Christmas slowdown, and $TLSA @TizianaLS looks to be entering one of the most pivotal windows in its history. Coming weeks may determine how the entire 2026 valuation story unfolds.

@PolareanImaging All shareholders who have lost everything are welcome.

Join Polarean at RSNA 2025 — and at the Xenon MRI Social! ✨ Xenon MRI Social: Network with the Experts 📅 Tuesday, Dec 2 | 🕕 6:00–8:30 PM (Open House) 📍 The TAP at Hyatt Regency McCormick Place Connect with peers, meet the experts behind #XenonMRI, and discover how functional imaging is transforming patient care across radiology and pulmonary medicine! 🔗 More event details and RSVP: lp.uniqo.de/KPKBqo And remember to visit us at Booth #3980 throughout RSNA to explore what’s new in functional lung imaging. #RSNA2025 #Radiology #LungHealth #Pulmonology #PulmonaryImaging #MRI #XenonMRISocial #MedicalImaging #Celebration

@DonaldPond6 Most share prices go up and down on short term influences and not a lot changes. Are we not In a transitional moment for this company. You don't find them often.

Sold some #FTC at 141.5 yesterday, and it has absolutely boomed since. Now 156 to sell. What a beast it has become.

@DomPosen excellent post much appreciated

1/10 THE BIG TAKEAWAYS FROM $TLSA PRESENTATION Tiziana CEO Ivor Elrifi spoke at the ROTH Conference. While no commercial news was announced, he hinted at key developments that could impact the future of Foralumab & $TLSA. Here’s what stood out 👇

@ZafarQuraishi11 @PowerMetRes finally washing our hands of RRR and Mr Bell would be a relief.

@ge35015665 @PowerMetRes Sadly, yes. I wonder what else we were correct about when it comes to #POW??

#POW #KAT Finally Coetzee leaving and Paul Johnson popping up here.Perhaps it will breath some life back into the Hanetti Project

@ZafarQuraishi11 you were spot on

@ge35015665 Unless the Haneti drill was an orchestrated drill for deception, the project is dead. 24% at surface and zero below does not warrant a single penny being spent on it now. At least I hope it's not all smoke and mirrors!

Double manufacturing capacity!! Lot more orders expected.

@TheLastDegree Hopefully feed a through To Ark.

Gentile adding another 5Mil shares - $ZNG.v stellar stepout results lately, bigger trend is up. So far +75% since entry Dec 2023

Cheers very clear, worth a read

#ARK Arkle Group Eleven started a raise for $1.5m following day increased to $2m now gone up to $3m. Hopefully some comes our way. Anyway positive interest in Irish mining.

#ARK placing raising £215000 to very tight holders. The two directors have put up £100 grand and £50 grand. Good to see directors not giving the company away at the lows

@ABridgen well done great effort

Today is the day, I will be on my feet in the chamber around 2:30 pm today. First debate on Trends in Excess Deaths. You can watch on Parliament TVor on BBC Parliament, if you're in London, there will be space in the Public Gallery of the House of Commons too.

No,,just every stock I follow on it